Thomas Ryll's Insider Trades & SAST Disclosures
Thomas Ryll's most recent trade in Immunogen, Inc. was a trade of 3,849 Common Stock done at an average price of $5.5 . Disclosure was reported to the exchange on June 30, 2021.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Thomas Ryll.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunogen, Inc. | Thomas Ryll | SVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 5.52 per share. | 30 Jun 2021 | 3,849 | 84,714 (0%) | 0% | 5.5 | 21,246 | Common Stock |
| Immunogen, Inc. | Thomas Ryll | VP, Technical Operations | Grant, award, or other acquisition of securities at price $ 3.91 per share. | 30 Jun 2020 | 5,241 | 80,865 (0%) | 0% | 3.9 | 20,492 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges